State Street
ANRO icon

State Street’s Alto Neuroscience ANRO Stock Holding History

State Street’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.48M Buy
199,503
+68,838
+53% +$1.28M ﹤0.01% 3003
2025
Q4 		$2.33M Buy
130,665
+27,480
+27% +$346K ﹤0.01% 3293
2025
Q3 		$415K Sell
103,185
-1,549
-1% -$5.14K ﹤0.01% 3704
2025
Q2 		$230K Sell
104,734
-233,982
-69% -$557K ﹤0.01% 3794
2025
Q1 		$732K Sell
338,716
-990
-0.3% -$3.54K ﹤0.01% 3502
2024
Q4 		$1.44M Buy
339,706
+102,849
+43% +$642K ﹤0.01% 3404
2024
Q3 		$2.71M Buy
236,857
+130,985
+124% +$1.6M ﹤0.01% 3215
2024
Q2 		$1.13M Buy
105,872
+80,472
+317% +$1.05M ﹤0.01% 3456
2024
Q1 		$390K Buy
+25,400
New +$398K ﹤0.01% 3710

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street's ANRO Position: Q1 2026 in Review

State Street increased its Alto Neuroscience (ANRO) stake by 53% in Q1 2026, buying an estimated $1.28M and bringing the position to 199,503 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

State Street first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • State Street held 199,503 shares of Alto Neuroscience worth $4.48M as of Q1 2026.
  • State Street bought 68,838 Alto Neuroscience shares in Q1 2026, an estimated $1.28M.
  • Alto Neuroscience made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3003 holding.
  • State Street first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.